Gas-X Extra Strength, 125 mg recall — Haleon US Holdings LLC (Class I)
Haleon US Holdings LLC is recorded by the U.S. Food and Drug Administration (FDA) as recalling Gas-X Extra Strength, 125 mg — a Class I recall, initiated 2026-06-04 and posted to the FDA enforcement report on 2026-06-17, under recall number D-0595-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “Chemical Contamination: contamination with a diluted propylene glycol-based coolant from a machine leakage during the packaging process.”. From the product description, the form is softgels, the strength given is 125 mg and the package is described as 120 SoftGels (UPC 3 00674 35041 9, b) and 72 SoftGels (UPC 3 00439 00572 1). The record carries UPC 300674350419 and 300439005721 rather than an NDC. Distribution is recorded as “Nationwide within the United States” — Nationwide (US), with the recalling firm on record in NJ, United States. It is the only recall number the FDA has filed under event ID 99125. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.
Regulatory snapshot
| Recall number | D-0595-2026 |
|---|---|
| FDA event ID | 99125 |
| Classification | Class I (most serious regulatory tier) |
| Status | Ongoing |
| Recalling firm | Haleon US Holdings LLC |
| Recall initiated | 2026-06-04 |
| Reported by FDA | 2026-06-17 |
| Report lag | 13 days from initiation to report |
| Distribution | Nationwide within the United States — Nationwide (US) |
| Firm location on record | NJ, United States |
| Product description (source) | Gas-X Extra Strength, SIMETHICONE 125 mg/ANTIGAS, packaged in a) 120 SoftGels (UPC 3 00674 35041 9, b) 72 SoftGels (UPC 3 00439 00572 1), Distributed by: Haleon, Warren, NJ 07059. |
Reason reported by FDA
Chemical Contamination: contamination with a diluted propylene glycol-based coolant from a machine leakage during the packaging process.
17 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.
Product identifiers in this record
7 identifying values matched by exact pattern in the 30-word product description above; each is a literal substring of it.
| Product named | Gas-X Extra Strength |
|---|---|
| Form | Softgels |
| Strength | 125 mg |
| Package | 120 SoftGels (UPC 3 00674 35041 9, b) · 72 SoftGels (UPC 3 00439 00572 1) |
| UPC | 300674350419 · 300439005721 |
| Distributed by | Haleon, Warren |
Other indexed recalls from Haleon US Holdings LLC
2 indexed records name Haleon US Holdings LLC as the recalling firm, across 2 FDA events, reported 2026-05-27 to 2026-06-17. A coverage-limited activity count over the ingested window, not a quality rating.
| Recall record | Recall number | FDA tier | Strength / form | Reported |
|---|---|---|---|---|
| Gas-X, 125 mg | D-0542-2026 | Class II | 125 mg · Softgels | 2026-05-27 |
Reported in the same month (2026-06)
74 enforcement reports carry a report date in 2026-06; these 2 are the Class I ones nearest this record.
| Recall record | Recall number | Recalling firm | FDA tier | Reported |
|---|---|---|---|---|
| DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL | D-0580-2026 | Sun Pharmaceutical Industries Inc | Class I | 2026-06-17 |
| BEEKEEPER'S NATURALS Saline Nasal Spray, 30 mL | D-0620-2026 | Beekeeper's Naturals Usa Inc. | Class I | 2026-06-17 |
Nearest Class I recalls by date
11 of 250 indexed records share the Class I tier; the 8 nearest to 2026-06-17 by report date are listed here.
| Recall record | Recall number | Recalling firm | Strength / form | Reported |
|---|---|---|---|---|
| BD ChloraPrep Clear, 2% | D-0624-2026 | Carefusion 213, LLC | 2% · Solution | 2026-07-01 |
| BD ChloraPrep FREPP Clear, 2% | D-0625-2026 | Carefusion 213, LLC | 2% · Solution | 2026-07-01 |
| MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%) | D-0553-2026 | Wisconsin Pharmacal Company | 2% · Cream | 2026-05-27 |
| Revitaderm Wound Care Gel, 0.1% | D-0692-2026 | Blaine Labs Inc | 0.1% · Gel | 2026-07-08 |
| Lactated Ringer's Injection USP, 1000 mL | D-0540-2026 | B Braun Medical Inc | 1000 mL · Injection | 2026-05-13 |
| Cetirizine Hydrochloride Tablets USP 5 mg | D-0732-2026 | JB Chemicals And Pharmaceuticals Ltd | 5 mg · Tablets | 2026-07-29 |
| Cyclophosphamide for Injection, 1 gram/vial | D-0743-2026 | Sunny Pharmtech Inc. | 1 gram/vial · for Injection | 2026-08-12 |
| Cyclophosphamide for Injection, 2 gram/vial | D-0744-2026 | Sunny Pharmtech Inc. | 2 gram/vial · for Injection | 2026-08-12 |
Reading this record
Class I is the FDA's own severity tier for the recall action — 11 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual. This record identifies packages by UPC 300674350419 and 300439005721 rather than by NDC.
Namespace context: the Class I index (11 records) and the recall hub (250 records, 118 FDA events); Haleon US Holdings LLC (2 indexed records) aggregates this firm across datasets.
Coverage and limits of this record
This page reflects the openFDA enforcement report for D-0595-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.
Source & provenance
- Official source
- https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0595-2026%22
- Source dataset
- openFDA Drug Enforcement API
- Publication date
- 2026-06-17
- Ingested
- 2026-08-22
- Record hash
a1be74e25aa1e64e
Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.